|
|
|
European Biopharmaceutical Review
|
| The Summer 2003 issue of EBR makes its entrance in time for the Annual BIO Convention in Washington this year - a city that has been the focus of much attention on the world stage in recent months. Politics aside, wars do not help settle global stock markets, even when relatively short in duration it seems. Thus the pain of closed stock markets continues as far as the global biotechnology industry is concerned. The more mature US market has been there, or somewhere close, before, as have certain countries in Europe. However, for the majority of European biotech companies the storm is far from over, as reflected in Ernst & Young's recently launched European Biotechnology Report 2003, reviewed in brief in this issue. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
PHASE II & IIa Clinical Trials
21-22 February 2012, Lancaster London Hotel, London
Learn how to overcome challenges in adapting the development process to achieve early Proof of Concept at Informa's 13th Annual Phase I & IIa Clinical Trials event.
More info >> |
|
 |
News and Press Releases |
 |
Topa Thermal Packaging introduces innovative pallet shipper
Topa Thermal Packaging has developed an innovative packaging for manufacturers that transport large quantities of temperature-sensitive products by road and air transport, such as vaccines and medicines. The ‘ClimateBox™ half PAG Pallet Shipper’ delivers significant time and cost savings, thanks to an efficient filling system.
More info >> |
|
|
